These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36729924)

  • 1. Postural Tachycardia Syndrome and COVID-19: Focus on Ivabradine Therapy.
    Dixit K; Frishman WH
    Cardiol Rev; 2024 May-Jun 01; 32(3):279-284. PubMed ID: 36729924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivabradine in Postural Orthostatic Tachycardia Syndrome: A Review of the Literature.
    Tahir F; Bin Arif T; Majid Z; Ahmed J; Khalid M
    Cureus; 2020 Apr; 12(4):e7868. PubMed ID: 32489723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivabradine for the Treatment of Postural Orthostatic Tachycardia Syndrome: A Systematic Review.
    Gee ME; Watkins AK; Brown JN; Young EJA
    Am J Cardiovasc Drugs; 2018 Jun; 18(3):195-204. PubMed ID: 29330767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome.
    Taub PR; Zadourian A; Lo HC; Ormiston CK; Golshan S; Hsu JC
    J Am Coll Cardiol; 2021 Feb; 77(7):861-871. PubMed ID: 33602468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postural orthostatic tachycardia syndrome as a sequela of COVID-19.
    Ormiston CK; Świątkiewicz I; Taub PR
    Heart Rhythm; 2022 Nov; 19(11):1880-1889. PubMed ID: 35853576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postural Orthostatic Tachycardia Syndrome: Mechanisms and New Therapies.
    Mar PL; Raj SR
    Annu Rev Med; 2020 Jan; 71():235-248. PubMed ID: 31412221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postural orthostatic tachycardia syndrome: pathophysiology, management, and experimental therapies.
    Narasimhan B; Aggarwal D; Satish P; Kantharia B; Aronow WS
    Expert Opin Investig Drugs; 2022 Oct; 31(10):1017-1025. PubMed ID: 36094001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1.
    Vernino S; Bourne KM; Stiles LE; Grubb BP; Fedorowski A; Stewart JM; Arnold AC; Pace LA; Axelsson J; Boris JR; Moak JP; Goodman BP; Chémali KR; Chung TH; Goldstein DS; Diedrich A; Miglis MG; Cortez MM; Miller AJ; Freeman R; Biaggioni I; Rowe PC; Sheldon RS; Shibao CA; Systrom DM; Cook GA; Doherty TA; Abdallah HI; Darbari A; Raj SR
    Auton Neurosci; 2021 Nov; 235():102828. PubMed ID: 34144933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivabradine in Postural Orthostatic Tachycardia Syndrome: Preliminary Experience in Children.
    Delle Donne G; Rosés Noguer F; Till J; Salukhe T; Prasad SK; Daubeney PEF
    Am J Cardiovasc Drugs; 2018 Feb; 18(1):59-63. PubMed ID: 29027608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postural tachycardia syndrome and inappropriate sinus tachycardia: role of autonomic modulation and sinus node automaticity.
    Nwazue VC; Paranjape SY; Black BK; Biaggioni I; Diedrich A; Dupont WD; Robertson D; Raj SR
    J Am Heart Assoc; 2014 Apr; 3(2):e000700. PubMed ID: 24721800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postural Orthostatic Tachycardia Syndrome After COVID-19: A Systematic Review of Therapeutic Interventions.
    Abbate G; De Iulio B; Thomas G; Priday A; Biondi-Zoccai G; Markley R; Abbate A
    J Cardiovasc Pharmacol; 2023 Jul; 82(1):23-31. PubMed ID: 37094584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience.
    Ruzieh M; Sirianni N; Ammari Z; Dasa O; Alhazmi L; Karabin B; Grubb B
    Pacing Clin Electrophysiol; 2017 Nov; 40(11):1242-1245. PubMed ID: 28846151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pharmacotherapeutic options for the treatment of postural orthostatic tachycardia syndrome.
    Lyonga Ngonge A; Nyange C; Ghali JK
    Expert Opin Pharmacother; 2024 Feb; 25(2):181-188. PubMed ID: 38465412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivabradine effects on COVID-19-associated postural orthostatic tachycardia syndrome: a single center prospective study.
    Abdelnabi M; Saleh Y; Ahmed A; Benjanuwattra J; Leelaviwat N; Almaghraby A
    Am J Cardiovasc Dis; 2023; 13(3):162-167. PubMed ID: 37469536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postural orthostatic tachycardia syndrome (POTS).
    Sidhu B; Obiechina N; Rattu N; Mitra S
    BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24042210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is ivabradine a wonder drug for atypical POTS?
    Cheema MA; Zain MA; Ullah W; Cheema K
    BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 31005863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Ivabradine on the Heart Rate and Sympathovagal Balance in Postural Tachycardia Syndrome Patients.
    Barzilai M; Jacob G
    Rambam Maimonides Med J; 2015 Jul; 6(3):. PubMed ID: 26241226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivabradine in children with postural orthostatic tachycardia syndrome: a retrospective study.
    Towheed A; Nesheiwat Z; Mangi MA; Karabin B; Grubb BP
    Cardiol Young; 2020 Jul; 30(7):975-979. PubMed ID: 32498748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy for postural tachycardia syndrome.
    Miller AJ; Raj SR
    Auton Neurosci; 2018 Dec; 215():28-36. PubMed ID: 29753556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine.
    O'Sullivan JS; Lyne A; Vaughan CJ
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34127505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.